PIK3CA and endometrial cancer: have shown the co-existence of PTEN and PIK3CA mutations in endometrial cancers, and these results are reflected by the NGS data in our series: Of the 5 patients in this series who had PTEN mutations, 3 co-exhibited PIK3CA mutations (60%) (27).